Comparing the efficacy of regorafenib and 5-fluorouracil-based rechallenge chemotherapy in the third-line treatment of metastatic colorectal cancer

Regorafenib, Medicine, Colorectal cancer, Internal medicine, Hazard ratio, Chemotherapy, Oncology, Surgical oncology, Placebo, Fluorouracil, Regimen, Bevacizumab, Oxaliplatin, Surgery, Cancer, Confidence interval, Pathology